FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4074401000001100: Report all adverse reactions to the CSM (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072501000001113 Report all adverse reactions to the CSM en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829301000001115 Report all adverse reactions to the CSM (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report all adverse reactions to the CSM Is a CSM warning status messages true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ammonaps 500mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Cystagon 150mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Cystagon 50mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Mercaptamine 150mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Mercaptamine 50mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Leflunomide 100mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Leflunomide 20mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lornoxicam 8mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lornoxicam 8.6mg injection (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Xefo 8.6mg injection (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Xefo 8mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Xefo 4mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Dynastat 40mg injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Dynastat 40mg injection (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Parecoxib 40mg injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Parecoxib 40mg injection (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rofecoxib 50mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Leflunomide 10mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Arava 100mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Arava 20mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Arava 10mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Brexidol 20mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Piroxicam-beta-cyclodextrin 191.3mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Arcoxia 120mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Arcoxia 90mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Arcoxia 60mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Etoricoxib 120mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Etoricoxib 90mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Etoricoxib 60mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lornoxicam 4mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tacrolimus monohydrate 0.1% ointment CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tacrolimus monohydrate 0.03% ointment CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ketotifen 250micrograms/mL eye drops CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Carmellose sodium 1% single-use eye drops - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Celluvisc 1% single-use eye drops CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Bimatoprost 0.3mg/mL eye drops CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Travoprost 40micrograms/mL eye drops CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Latanoprost+timolol 0.005%/0.5% eye drops CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Brinzolamide 10mg/mL eye drops - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Timoptol LA 0.5% liquid eye gel CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Timoptol LA 0.25% liquid eye gel CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Timolol 0.25% liquid eye gel - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fluticasone propionate 400micrograms single-use nasal drops - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Flixonase 400micrograms Nasule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ganciclovir 0.15% eye gel CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lomefloxacin 0.3% eye drops CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Isovorin 175mg/17.5mL injection CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Isovorin 50mg/5mL injection CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Isovorin 25mg/2.5mL injection CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Levofolinic acid 175mg/17.5mL injection - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Levofolinic acid 25mg/2.5mL injection - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Glamin intravenous infusion CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rasburicase 1.5mg infusion (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rasburicase 7.5mg infusion (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fasturtec 7.5mg infusion (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fasturtec 1.5mg infusion (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Haem arginate 250mg/10mL infusion concentrate - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Normosang 250mg/10mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Magnesiocard 2.5mmol/614.8mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Magnesium aspartate hydrochloride 2.5mmol/614.8mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Iron dextran complex 100mg/2mL injection - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
CosmoFer 100mg/2mL injection CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 10micrograms/0.4mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 15micrograms/0.375mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 20micrograms/0.5mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 30micrograms/0.3mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 40micrograms/0.4mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 50micrograms/0.5mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 60micrograms/0.3mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 80micrograms/0.4mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 100micrograms/0.5mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 150micrograms/0.3mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Darbepoetin alfa 300micrograms/0.6mL prefilled syringe - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 300micrograms/0.6mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 150micrograms/0.3mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 100micrograms/0.5mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 80micrograms/0.4mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 60micrograms/0.3mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 50micrograms/0.5mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 40micrograms/0.4mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 30micrograms/0.3mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 20micrograms/0.5mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 15micrograms/0.375mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aranesp 10micrograms/0.4mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Duraphat 2800ppm Fluoride toothpaste CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sevelamer 403mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sevelamer 800mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Renagel 800mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Renagel 403mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Subutex 400micrograms sublingual tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Palladone-SR 2mg m/r capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hydromorphone hydrochloride 24mg m/r capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hydromorphone hydrochloride 16mg m/r capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hydromorphone hydrochloride 8mg m/r capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hydromorphone hydrochloride 4mg m/r capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hydromorphone hydrochloride 2mg m/r capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Palladone 2.6mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hydromorphone hydrochloride 2.6mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Palladone 1.3mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hydromorphone hydrochloride 1.3mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier

Start Previous Page 3 of 8 Next End

This concept is not in any reference sets

Back to Start